Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.

    Welcome the new year surrounded by loved ones at Mövenpick’s dazzling New Year’s Eve Glitter Gala. Enjoy a spectacular night filled with a lavish buffet, vibrant bar offerings, and an impressive lineup of entertainment including a live DJ, band, belly dancer, and Tanoura show. The evening is designed for families and friends to celebrate side by […] The post New Year’s Eve Glitter Gala appeared first on Web-Release.